JPS5512435B2 - - Google Patents

Info

Publication number
JPS5512435B2
JPS5512435B2 JP6630172A JP6630172A JPS5512435B2 JP S5512435 B2 JPS5512435 B2 JP S5512435B2 JP 6630172 A JP6630172 A JP 6630172A JP 6630172 A JP6630172 A JP 6630172A JP S5512435 B2 JPS5512435 B2 JP S5512435B2
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP6630172A
Other languages
Japanese (ja)
Other versions
JPS4925121A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP6630172A priority Critical patent/JPS5512435B2/ja
Priority to HUTA1257A priority patent/HU166029B/hu
Priority to FR7320833A priority patent/FR2190414B1/fr
Priority to NL7308048A priority patent/NL7308048A/xx
Priority to US371528A priority patent/US3925357A/en
Priority to CS4540A priority patent/CS168036B2/cs
Priority to BE132836A priority patent/BE801588A/xx
Priority to DE2332840A priority patent/DE2332840A1/de
Priority to SE7309138A priority patent/SE402916B/xx
Priority to CA175,329A priority patent/CA996548A/en
Priority to AT576473A priority patent/AT325206B/de
Priority to CH955873A priority patent/CH573435A5/xx
Priority to PL1973163783A priority patent/PL92969B1/pl
Priority to GB3147473A priority patent/GB1386566A/en
Priority to AU57600/73A priority patent/AU469986B2/en
Publication of JPS4925121A publication Critical patent/JPS4925121A/ja
Publication of JPS5512435B2 publication Critical patent/JPS5512435B2/ja
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP6630172A 1972-07-01 1972-07-01 Expired JPS5512435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Priority Applications (15)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1972-07-01
HUTA1257A HU166029B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1973-06-01
FR7320833A FR2190414B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1973-06-07
NL7308048A NL7308048A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1973-06-08
US371528A US3925357A (en) 1972-07-01 1973-06-19 ' -sulfobenzylpenicillin salt
CS4540A CS168036B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1973-06-25
BE132836A BE801588A (fr) 1972-07-01 1973-06-28 Nouveaux sels d'alpha-sulfobenzylpenicilline
DE2332840A DE2332840A1 (de) 1972-07-01 1973-06-28 Alpha-sulfobenzylpenicillindiaminsalze und verfahren zu ihrer herstellung
SE7309138A SE402916B (sv) 1972-07-01 1973-06-28 Sett att framstella nya alfa-sulfobensylpenicillindiaminsalter
CA175,329A CA996548A (en) 1972-07-01 1973-06-29 .alpha.-SULFOBENZYLPENICILLIN SALT
AT576473A AT325206B (de) 1972-07-01 1973-06-29 Verfahren zur herstellung von neuen alpha-sulfobenzylpenicillinsalzen
CH955873A CH573435A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1973-06-29
PL1973163783A PL92969B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1973-07-02
GB3147473A GB1386566A (en) 1972-07-01 1973-07-02 Alpha-sulphobenzyl penicillin salts
AU57600/73A AU469986B2 (en) 1972-07-01 1973-07-02 Sulfobenzylpenicillin salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1972-07-01

Publications (2)

Publication Number Publication Date
JPS4925121A JPS4925121A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-03-06
JPS5512435B2 true JPS5512435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-04-02

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6630172A Expired JPS5512435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-07-01 1972-07-01

Country Status (15)

Country Link
US (1) US3925357A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5512435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT325206B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU469986B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE801588A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA996548A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH573435A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS168036B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2332840A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2190414B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1386566A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU166029B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7308048A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL92969B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE402916B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1978-07-29 1980-02-13
EP1953162B9 (de) * 2001-02-24 2012-10-31 Boehringer Ingelheim Pharma GmbH & Co. KG Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20080251A1 (es) * 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2016079A1 (de) 2006-05-04 2009-01-21 Boehringer Ingelheim International GmbH Polymorphe
EP1852108A1 (en) * 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
JP5769966B2 (ja) * 2007-08-17 2015-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Fab関連疾患治療用プリン誘導体
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
ES2764251T3 (es) * 2008-08-15 2020-06-02 Boehringer Ingelheim Int Inhibidores de DPP-4 para uso en el tratamiento de curación de heridas en pacientes diabéticos
JP2012502081A (ja) 2008-09-10 2012-01-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連症状の治療のための組み合わせ治療
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
JP2013512229A (ja) 2009-11-27 2013-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療
EP2566469B1 (en) 2010-05-05 2022-12-21 Boehringer Ingelheim International GmbH Combination therapy
EP3366304B1 (en) 2010-06-24 2020-05-13 Boehringer Ingelheim International GmbH Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
DK2731947T3 (en) 2011-07-15 2019-04-23 Boehringer Ingelheim Int SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
ES2929025T3 (es) 2012-05-14 2022-11-24 Boehringer Ingelheim Int Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP6615109B2 (ja) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Dpp−4阻害薬の医学的使用
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
AT325206B (de) 1975-10-10
US3925357A (en) 1975-12-09
JPS4925121A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-03-06
CA996548A (en) 1976-09-07
GB1386566A (en) 1975-03-12
DE2332840A1 (de) 1974-01-17
CS168036B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-05-28
CH573435A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-03-15
PL92969B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-04-30
SE402916B (sv) 1978-07-24
NL7308048A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-03
HU166029B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-12-28
FR2190414A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-02-01
AU5760073A (en) 1975-01-09
BE801588A (fr) 1973-12-28
FR2190414B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-07-02
AU469986B2 (en) 1976-02-26

Similar Documents

Publication Publication Date Title
JPS5512435B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS152750B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS153932B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS154499B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS155083B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS155628B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH562756A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH564457A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG18291A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG18528A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG18739A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG18930A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG18949A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG20192A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG21266A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH1527073A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH334473A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH561126A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH561350A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH561501A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH561697A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH562023A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH562165A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH562404A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH562819A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)